Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy.

@article{Zhang2009IsolationSA,
  title={Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy.},
  author={Chaowei Zhang and John G. Ondeyka and Deborah L. Zink and Ángela Basilio and Francisca Vicente and Javier Collado and Gonzalo Platas and Joann Huber and Karen Dorso and Mary R. Motyl and Kevin M. Byrne and Sheo B. Singh},
  journal={Bioorganic \& medicinal chemistry},
  year={2009},
  volume={17 6},
  pages={
          2162-6
        }
}
View on PubMed
doi.org
21 Citations
Background Citations
1
Methods Citations
1

Figures and Tables from this paper

21 Citations

Citation Type

Citation Type

Isolation, structure elucidation and antibacterial activity of a new tetramic acid, ascosetin
TLDR
Ascosetin inhibited bacterial growth with 2–16 μg ml−1 MIC values against Gram-positive strains including methicillin-resistant S. aureus and showed selectivity for bacterial growth inhibition compared with fungal but not mammalian cells.
Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein S4
TLDR
Screening of microbial extracts using antisense-sensitized rpsD Staphylococcus aureus strain led to isolation of okilactomycin and four new congeners from Streptomyces scabrisporus, and all compounds showed a slight preferential inhibition of RNA synthesis over DNA and protein synthesis.
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screening.
TLDR
Altersolanol P exhibited Gram-positive antibacterial activity and inhibited the growth of Gram-negative Haemophilus influenzae and exhibited well aligned with the corresponding chemical shifts predicted by DFT calculations.
Isolation, structure elucidation, and antibacterial activity of methiosetin, a tetramic acid from a tropical sooty mold (Capnodium sp.).
TLDR
In an antibiotic screening program for new drug leads with new modes of action using antisense Staphylococcus aureus Fitness Test screening, a new tetramic acid, methiosetin, is discovered from a tropical sooty mold, Capnodium sp.
Discovery and antibacterial activity of glabramycin A–C from Neosartorya glabra by an antisense strategy
TLDR
Glabramycin C showed strong antibiotics activity against Streptococcus pneumoniae and modest antibiotic activity against Staphylococcus aureus, and the isolation, structure, relative configuration and antibacterial activity, and plausible biogenesis of these compounds have been discussed.
Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.
  • Sheo B. Singh
  • Biology, Medicine
    Bioorganic & medicinal chemistry
  • 2016
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.
Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities.
Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages.
TLDR
Antisense technology using synthetic siRNAs has been used in knocking down genes in bacteria and over the years this has evolved into a powerful tool for elucidating the roles of various genes mediating infectivity and survival in mycobacteria.
A review on different approaches to isolate antibiotic compounds from fungi
TLDR
The revolutionizing impacts of the post-genomic era also aided these search in the form of various omics-based and biosynthetic approaches, which facilitate the invention of all-new compounds but contribute in the modification of existing compounds through which the compounds can serve as better drug candidates.
...
1
2
3
...

References

SHOWING 1-10 OF 20 REFERENCES
Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.
TLDR
It was determined that potential reactivity of the enone moiety does not play a key role in the biological activity of platensimycin and cyclohexenone ring conformation renders for the stronger binding interaction with the enzyme.
Coniothyrione, a chlorocyclopentandienylbenzopyrone as a bacterial protein synthesis inhibitor discovered by antisense technology.
TLDR
The antisense-rpsD gene-sensitized two-plate assay led to the discovery of a novel chlorinated cyclopentandienylbenzopyrone antibiotic, coniothyrione, C14H9ClO6, isolated from Coniothyrium cerealis MF7209.
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
TLDR
Platensimycin demonstrates strong, broad-spectrum Gram-positive antibacterial activity by selectively inhibiting cellular lipid biosynthesis through the selective targeting of β-ketoacyl-(acyl-carrier-protein (ACP) in the synthetic pathway of fatty acids.
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
TLDR
Platencin shows potent in vivo efficacy without any observed toxicity, emphasizing the fact that more antibiotics with novel structures and new modes of action can be discovered by using this antisense differential sensitivity whole-cell screening paradigm.
Discovery of FabH/FabF Inhibitors from Natural Products
TLDR
The mechanism of decreased target protein production by expression of antisense RNA was investigated using Northern blotting and revealed that the antisenseRNA acts posttranscriptionally by targeting mRNA, leading to 5′ mRNA degradation.
Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy.
TLDR
This work describes, using an antisense-sensitized rpsD Streptomyces aureus strain, the discovery and activity of lucensimycins A and B, a potential target for the discovery of antibacterial agents.
Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors*
TLDR
A high throughput assay that identifies inhibitors simultaneously against multiple targets within the FASII pathway of most bacterial pathogens and isolated an inhibitor, bischloroanthrabenzoxocinone (BABX) with a new structure was developed, which will aid in future drug discovery.
Antibacterial Agents That Inhibit Lipid A Biosynthesis
TLDR
Synthetic antibacterials were identified that inhibit the second enzyme (a unique deacetylase) of lipid A biosynthesis that constitutes the outer monolayer of the outer membrane of Gram-negative bacteria and is essential for bacterial growth.
A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus
TLDR
A cell‐based, drug‐screening assay is described, wherein expression of an antisense RNA confers specific sensitivity to compounds targeting that gene product, thereby greatly facilitating the search for new antibiotics.
The rpsD gene, encoding ribosomal protein S4, is autogenously regulated in Bacillus subtilis
TLDR
The B. subtilis rpsD gene, encoding ribosomal protein S4, was found to be subject to autogenous control and exhibits little sequence homology to the E. coli alpha operon leader but may be able to form a pseudoknotlike structure similar to that found in E. Escherichia coli.
...
1
2
...